[raw]

BRINGING IV-EQUIVALENT
DIURESIS* TO

THEIR
COMFORT
ZONE

For patients with fluid overload, only FUROSCIX­ is FDA-approved to deliver subcutaneous, IV-equivalent* treatment at home.

See if furoscix is right for your patients

*based on similar systemic exposure and diuresis

Clinical Results

FUROSCIX leverages the standard-of-care diuretic furosemide for a new at-home treatment option for patients with fluid overload.

Learn more about furoscix clinical data

Ease-of-use

98.3% of subjects reported the Instructions for Use were not difficult to follow in a Human Factors study.1

Learn more about furoscix use

Service and support

FUROSCIX DirectSM offers services and support to clinicians, patients, and caregivers to get them started with FUROSCIX.

Learn more about furoscix direct

References: 1. Andre AD, Mohr J, Cornelius B, et al. 2020. Successful validation of a wearable, on-body infusor for subcutaneous administration of Furoscix® in heart failure patients, caregivers, and health care practitioners. [Poster]. The HFSA Virtual Annual Scientific Meeting, September 30 – October 6, 2020.

[/raw]